A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence
NCT00269724
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Urinary Incontinence
Interventions
DRUG:
OROS® oxybutynin
Sponsor
Alza Corporation, DE, USA